世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

世界と中国の医薬品再利用市場の規模、現状、見通し 2021-2027年


Global and China Drug Repurposing Market Size, Status and Forecast 2021-2027

市場分析と洞察。医薬品再利用の世界市場 Drug Repurposingの世界市場規模は、2020年のXX百万米ドルから2021-2027年の間にXX%のCAGRで、2027年にXX百万米ドルに達すると予測されています。 本レポートは、業界... もっと見る

 

 

出版社 出版年月 電子版価格 言語
QYResearch
QYリサーチ
2021年12月3日 US$3,900
シングルユーザライセンス
ライセンス・価格情報
注文方法はこちら
英語

※当ページの内容はウェブ更新時の情報です。
最新版の価格やページ数などの情報についてはお問合せください。

日本語のページは自動翻訳を利用し作成しています。
実際のレポートは英文のみでご納品いたします。


 

サマリー

市場分析と洞察。医薬品再利用の世界市場
Drug Repurposingの世界市場規模は、2020年のXX百万米ドルから2021-2027年の間にXX%のCAGRで、2027年にXX百万米ドルに達すると予測されています。
本レポートは、業界標準の正確な分析と高いデータ整合性により、世界のDrug Repurposing市場で得られる主要な機会を明らかにし、プレイヤーが市場での確固たる地位を獲得するのに役立つことを目的としています。本レポートの購入者は、検証された信頼性の高い市場予測にアクセスすることができ、その中には収益面での世界のDrug Repurposing市場の全体的なサイズも含まれています。
全体として、本レポートは、プレイヤーが競合他社に対して優位に立ち、世界の医薬品再利用市場で永続的な成功を収めるための有効なツールであることを証明しています。本レポートに掲載されているすべての調査結果、データ、情報は、信頼できる情報源の助けを借りて検証、再検証されています。本レポートを執筆したアナリストは、世界のDrug Repurposing市場を詳細に調査するために、独自の業界最高の調査・分析手法を採用しました。

世界の医薬品再利用の範囲と市場規模
Drug Repurposing市場は、企業別、地域(国)別、タイプ別、アプリケーション別に分類されています。世界のDrug Repurposing市場のプレイヤー、ステークホルダー、その他の参加者は、本レポートを強力なリソースとして活用することで、優位に立つことができるでしょう。セグメント別分析では、2016年から2027年の期間で、タイプ別とアプリケーション別の収益と予測に焦点を当てています。

タイプ別セグメント
静脈内投与
経口投与

用途別セグメント
心血管障害
中枢神経系疾患
オンコロジー
その他

地域別
北アメリカ
アメリカ
カナダ
ヨーロッパ
ドイツ
フランス
U.K.
イタリア
ロシア
北欧
その他のヨーロッパ諸国
アジア太平洋地域
中国
日本
韓国
東南アジア
インド
オーストラリア
その他のアジア諸国
ラテンアメリカ
メキシコ
ブラジル
その他のラテンアメリカ
中近東・アフリカ
トルコ
サウジアラビア
アラブ首長国連邦
その他の中東・アフリカ地域

会社別
ファイザー
ロシュ
ノバルティス社
アボット・ヘルスケア
ジョンソン・エンド・ジョンソン
サンドラッグ
マイラン社
テバ・ファーマシューティカルズ


ページTOPに戻る


目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Drug Repurposing Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Intravenous
1.2.3 Oral
1.3 Market by Application
1.3.1 Global Drug Repurposing Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Cardiovascular Disorders
1.3.3 Central Nervous Disorders
1.3.4 Oncology
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Drug Repurposing Market Perspective (2016-2027)
2.2 Drug Repurposing Growth Trends by Regions
2.2.1 Drug Repurposing Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Drug Repurposing Historic Market Share by Regions (2016-2021)
2.2.3 Drug Repurposing Forecasted Market Size by Regions (2022-2027)
2.3 Drug Repurposing Industry Dynamic
2.3.1 Drug Repurposing Market Trends
2.3.2 Drug Repurposing Market Drivers
2.3.3 Drug Repurposing Market Challenges
2.3.4 Drug Repurposing Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Drug Repurposing Players by Revenue
3.1.1 Global Top Drug Repurposing Players by Revenue (2016-2021)
3.1.2 Global Drug Repurposing Revenue Market Share by Players (2016-2021)
3.2 Global Drug Repurposing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Drug Repurposing Revenue
3.4 Global Drug Repurposing Market Concentration Ratio
3.4.1 Global Drug Repurposing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Drug Repurposing Revenue in 2020
3.5 Drug Repurposing Key Players Head office and Area Served
3.6 Key Players Drug Repurposing Product Solution and Service
3.7 Date of Enter into Drug Repurposing Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Drug Repurposing Breakdown Data by Type
4.1 Global Drug Repurposing Historic Market Size by Type (2016-2021)
4.2 Global Drug Repurposing Forecasted Market Size by Type (2022-2027)

5 Drug Repurposing Breakdown Data by Application
5.1 Global Drug Repurposing Historic Market Size by Application (2016-2021)
5.2 Global Drug Repurposing Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Drug Repurposing Market Size (2016-2027)
6.2 North America Drug Repurposing Market Size by Type
6.2.1 North America Drug Repurposing Market Size by Type (2016-2021)
6.2.2 North America Drug Repurposing Market Size by Type (2022-2027)
6.2.3 North America Drug Repurposing Market Size by Type (2016-2027)
6.3 North America Drug Repurposing Market Size by Application
6.3.1 North America Drug Repurposing Market Size by Application (2016-2021)
6.3.2 North America Drug Repurposing Market Size by Application (2022-2027)
6.3.3 North America Drug Repurposing Market Size by Application (2016-2027)
6.4 North America Drug Repurposing Market Size by Country
6.4.1 North America Drug Repurposing Market Size by Country (2016-2021)
6.4.2 North America Drug Repurposing Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Drug Repurposing Market Size (2016-2027)
7.2 Europe Drug Repurposing Market Size by Type
7.2.1 Europe Drug Repurposing Market Size by Type (2016-2021)
7.2.2 Europe Drug Repurposing Market Size by Type (2022-2027)
7.2.3 Europe Drug Repurposing Market Size by Type (2016-2027)
7.3 Europe Drug Repurposing Market Size by Application
7.3.1 Europe Drug Repurposing Market Size by Application (2016-2021)
7.3.2 Europe Drug Repurposing Market Size by Application (2022-2027)
7.3.3 Europe Drug Repurposing Market Size by Application (2016-2027)
7.4 Europe Drug Repurposing Market Size by Country
7.4.1 Europe Drug Repurposing Market Size by Country (2016-2021)
7.4.2 Europe Drug Repurposing Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Drug Repurposing Market Size (2016-2027)
8.2 Asia-Pacific Drug Repurposing Market Size by Type
8.2.1 Asia-Pacific Drug Repurposing Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Drug Repurposing Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Drug Repurposing Market Size by Type (2016-2027)
8.3 Asia-Pacific Drug Repurposing Market Size by Application
8.3.1 Asia-Pacific Drug Repurposing Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Drug Repurposing Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Drug Repurposing Market Size by Application (2016-2027)
8.4 Asia-Pacific Drug Repurposing Market Size by Region
8.4.1 Asia-Pacific Drug Repurposing Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Drug Repurposing Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Drug Repurposing Market Size (2016-2027)
9.2 Latin America Drug Repurposing Market Size by Type
9.2.1 Latin America Drug Repurposing Market Size by Type (2016-2021)
9.2.2 Latin America Drug Repurposing Market Size by Type (2022-2027)
9.2.3 Latin America Drug Repurposing Market Size by Type (2016-2027)
9.3 Latin America Drug Repurposing Market Size by Application
9.3.1 Latin America Drug Repurposing Market Size by Application (2016-2021)
9.3.2 Latin America Drug Repurposing Market Size by Application (2022-2027)
9.3.3 Latin America Drug Repurposing Market Size by Application (2016-2027)
9.4 Latin America Drug Repurposing Market Size by Country
9.4.1 Latin America Drug Repurposing Market Size by Country (2016-2021)
9.4.2 Latin America Drug Repurposing Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Drug Repurposing Market Size (2016-2027)
10.2 Middle East & Africa Drug Repurposing Market Size by Type
10.2.1 Middle East & Africa Drug Repurposing Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Drug Repurposing Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Drug Repurposing Market Size by Type (2016-2027)
10.3 Middle East & Africa Drug Repurposing Market Size by Application
10.3.1 Middle East & Africa Drug Repurposing Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Drug Repurposing Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Drug Repurposing Market Size by Application (2016-2027)
10.4 Middle East & Africa Drug Repurposing Market Size by Country
10.4.1 Middle East & Africa Drug Repurposing Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Drug Repurposing Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Drug Repurposing Introduction
11.1.4 Pfizer Revenue in Drug Repurposing Business (2016-2021)
11.1.5 Pfizer Recent Development
11.2 Roche
11.2.1 Roche Company Details
11.2.2 Roche Business Overview
11.2.3 Roche Drug Repurposing Introduction
11.2.4 Roche Revenue in Drug Repurposing Business (2016-2021)
11.2.5 Roche Recent Development
11.3 Novartis AG
11.3.1 Novartis AG Company Details
11.3.2 Novartis AG Business Overview
11.3.3 Novartis AG Drug Repurposing Introduction
11.3.4 Novartis AG Revenue in Drug Repurposing Business (2016-2021)
11.3.5 Novartis AG Recent Development
11.4 Abbott Healthcare
11.4.1 Abbott Healthcare Company Details
11.4.2 Abbott Healthcare Business Overview
11.4.3 Abbott Healthcare Drug Repurposing Introduction
11.4.4 Abbott Healthcare Revenue in Drug Repurposing Business (2016-2021)
11.4.5 Abbott Healthcare Recent Development
11.5 Johnson & Johnson
11.5.1 Johnson & Johnson Company Details
11.5.2 Johnson & Johnson Business Overview
11.5.3 Johnson & Johnson Drug Repurposing Introduction
11.5.4 Johnson & Johnson Revenue in Drug Repurposing Business (2016-2021)
11.5.5 Johnson & Johnson Recent Development
11.6 Sandoz
11.6.1 Sandoz Company Details
11.6.2 Sandoz Business Overview
11.6.3 Sandoz Drug Repurposing Introduction
11.6.4 Sandoz Revenue in Drug Repurposing Business (2016-2021)
11.6.5 Sandoz Recent Development
11.7 Mylan Inc.
11.7.1 Mylan Inc. Company Details
11.7.2 Mylan Inc. Business Overview
11.7.3 Mylan Inc. Drug Repurposing Introduction
11.7.4 Mylan Inc. Revenue in Drug Repurposing Business (2016-2021)
11.7.5 Mylan Inc. Recent Development
11.8 Teva Pharmaceuticals
11.8.1 Teva Pharmaceuticals Company Details
11.8.2 Teva Pharmaceuticals Business Overview
11.8.3 Teva Pharmaceuticals Drug Repurposing Introduction
11.8.4 Teva Pharmaceuticals Revenue in Drug Repurposing Business (2016-2021)
11.8.5 Teva Pharmaceuticals Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

 

ページTOPに戻る


 

Summary

Market Analysis and Insights: Global Drug Repurposing Market
The global Drug Repurposing market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Drug Repurposing market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Drug Repurposing market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Drug Repurposing market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Drug Repurposing market.

Global Drug Repurposing Scope and Market Size
Drug Repurposing market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Drug Repurposing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Intravenous
Oral

Segment by Application
Cardiovascular Disorders
Central Nervous Disorders
Oncology
Others

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Pfizer
Roche
Novartis AG
Abbott Healthcare
Johnson & Johnson
Sandoz
Mylan Inc.
Teva Pharmaceuticals



ページTOPに戻る


Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Drug Repurposing Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Intravenous
1.2.3 Oral
1.3 Market by Application
1.3.1 Global Drug Repurposing Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Cardiovascular Disorders
1.3.3 Central Nervous Disorders
1.3.4 Oncology
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Drug Repurposing Market Perspective (2016-2027)
2.2 Drug Repurposing Growth Trends by Regions
2.2.1 Drug Repurposing Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Drug Repurposing Historic Market Share by Regions (2016-2021)
2.2.3 Drug Repurposing Forecasted Market Size by Regions (2022-2027)
2.3 Drug Repurposing Industry Dynamic
2.3.1 Drug Repurposing Market Trends
2.3.2 Drug Repurposing Market Drivers
2.3.3 Drug Repurposing Market Challenges
2.3.4 Drug Repurposing Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Drug Repurposing Players by Revenue
3.1.1 Global Top Drug Repurposing Players by Revenue (2016-2021)
3.1.2 Global Drug Repurposing Revenue Market Share by Players (2016-2021)
3.2 Global Drug Repurposing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Drug Repurposing Revenue
3.4 Global Drug Repurposing Market Concentration Ratio
3.4.1 Global Drug Repurposing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Drug Repurposing Revenue in 2020
3.5 Drug Repurposing Key Players Head office and Area Served
3.6 Key Players Drug Repurposing Product Solution and Service
3.7 Date of Enter into Drug Repurposing Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Drug Repurposing Breakdown Data by Type
4.1 Global Drug Repurposing Historic Market Size by Type (2016-2021)
4.2 Global Drug Repurposing Forecasted Market Size by Type (2022-2027)

5 Drug Repurposing Breakdown Data by Application
5.1 Global Drug Repurposing Historic Market Size by Application (2016-2021)
5.2 Global Drug Repurposing Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Drug Repurposing Market Size (2016-2027)
6.2 North America Drug Repurposing Market Size by Type
6.2.1 North America Drug Repurposing Market Size by Type (2016-2021)
6.2.2 North America Drug Repurposing Market Size by Type (2022-2027)
6.2.3 North America Drug Repurposing Market Size by Type (2016-2027)
6.3 North America Drug Repurposing Market Size by Application
6.3.1 North America Drug Repurposing Market Size by Application (2016-2021)
6.3.2 North America Drug Repurposing Market Size by Application (2022-2027)
6.3.3 North America Drug Repurposing Market Size by Application (2016-2027)
6.4 North America Drug Repurposing Market Size by Country
6.4.1 North America Drug Repurposing Market Size by Country (2016-2021)
6.4.2 North America Drug Repurposing Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Drug Repurposing Market Size (2016-2027)
7.2 Europe Drug Repurposing Market Size by Type
7.2.1 Europe Drug Repurposing Market Size by Type (2016-2021)
7.2.2 Europe Drug Repurposing Market Size by Type (2022-2027)
7.2.3 Europe Drug Repurposing Market Size by Type (2016-2027)
7.3 Europe Drug Repurposing Market Size by Application
7.3.1 Europe Drug Repurposing Market Size by Application (2016-2021)
7.3.2 Europe Drug Repurposing Market Size by Application (2022-2027)
7.3.3 Europe Drug Repurposing Market Size by Application (2016-2027)
7.4 Europe Drug Repurposing Market Size by Country
7.4.1 Europe Drug Repurposing Market Size by Country (2016-2021)
7.4.2 Europe Drug Repurposing Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Drug Repurposing Market Size (2016-2027)
8.2 Asia-Pacific Drug Repurposing Market Size by Type
8.2.1 Asia-Pacific Drug Repurposing Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Drug Repurposing Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Drug Repurposing Market Size by Type (2016-2027)
8.3 Asia-Pacific Drug Repurposing Market Size by Application
8.3.1 Asia-Pacific Drug Repurposing Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Drug Repurposing Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Drug Repurposing Market Size by Application (2016-2027)
8.4 Asia-Pacific Drug Repurposing Market Size by Region
8.4.1 Asia-Pacific Drug Repurposing Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Drug Repurposing Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Drug Repurposing Market Size (2016-2027)
9.2 Latin America Drug Repurposing Market Size by Type
9.2.1 Latin America Drug Repurposing Market Size by Type (2016-2021)
9.2.2 Latin America Drug Repurposing Market Size by Type (2022-2027)
9.2.3 Latin America Drug Repurposing Market Size by Type (2016-2027)
9.3 Latin America Drug Repurposing Market Size by Application
9.3.1 Latin America Drug Repurposing Market Size by Application (2016-2021)
9.3.2 Latin America Drug Repurposing Market Size by Application (2022-2027)
9.3.3 Latin America Drug Repurposing Market Size by Application (2016-2027)
9.4 Latin America Drug Repurposing Market Size by Country
9.4.1 Latin America Drug Repurposing Market Size by Country (2016-2021)
9.4.2 Latin America Drug Repurposing Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Drug Repurposing Market Size (2016-2027)
10.2 Middle East & Africa Drug Repurposing Market Size by Type
10.2.1 Middle East & Africa Drug Repurposing Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Drug Repurposing Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Drug Repurposing Market Size by Type (2016-2027)
10.3 Middle East & Africa Drug Repurposing Market Size by Application
10.3.1 Middle East & Africa Drug Repurposing Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Drug Repurposing Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Drug Repurposing Market Size by Application (2016-2027)
10.4 Middle East & Africa Drug Repurposing Market Size by Country
10.4.1 Middle East & Africa Drug Repurposing Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Drug Repurposing Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Drug Repurposing Introduction
11.1.4 Pfizer Revenue in Drug Repurposing Business (2016-2021)
11.1.5 Pfizer Recent Development
11.2 Roche
11.2.1 Roche Company Details
11.2.2 Roche Business Overview
11.2.3 Roche Drug Repurposing Introduction
11.2.4 Roche Revenue in Drug Repurposing Business (2016-2021)
11.2.5 Roche Recent Development
11.3 Novartis AG
11.3.1 Novartis AG Company Details
11.3.2 Novartis AG Business Overview
11.3.3 Novartis AG Drug Repurposing Introduction
11.3.4 Novartis AG Revenue in Drug Repurposing Business (2016-2021)
11.3.5 Novartis AG Recent Development
11.4 Abbott Healthcare
11.4.1 Abbott Healthcare Company Details
11.4.2 Abbott Healthcare Business Overview
11.4.3 Abbott Healthcare Drug Repurposing Introduction
11.4.4 Abbott Healthcare Revenue in Drug Repurposing Business (2016-2021)
11.4.5 Abbott Healthcare Recent Development
11.5 Johnson & Johnson
11.5.1 Johnson & Johnson Company Details
11.5.2 Johnson & Johnson Business Overview
11.5.3 Johnson & Johnson Drug Repurposing Introduction
11.5.4 Johnson & Johnson Revenue in Drug Repurposing Business (2016-2021)
11.5.5 Johnson & Johnson Recent Development
11.6 Sandoz
11.6.1 Sandoz Company Details
11.6.2 Sandoz Business Overview
11.6.3 Sandoz Drug Repurposing Introduction
11.6.4 Sandoz Revenue in Drug Repurposing Business (2016-2021)
11.6.5 Sandoz Recent Development
11.7 Mylan Inc.
11.7.1 Mylan Inc. Company Details
11.7.2 Mylan Inc. Business Overview
11.7.3 Mylan Inc. Drug Repurposing Introduction
11.7.4 Mylan Inc. Revenue in Drug Repurposing Business (2016-2021)
11.7.5 Mylan Inc. Recent Development
11.8 Teva Pharmaceuticals
11.8.1 Teva Pharmaceuticals Company Details
11.8.2 Teva Pharmaceuticals Business Overview
11.8.3 Teva Pharmaceuticals Drug Repurposing Introduction
11.8.4 Teva Pharmaceuticals Revenue in Drug Repurposing Business (2016-2021)
11.8.5 Teva Pharmaceuticals Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同じKEY WORD(china drug)の最新刊レポート


よくあるご質問


QYResearch社はどのような調査会社ですか?


QYリサーチ(QYResearch)は幅広い市場を対象に調査・レポート出版を行う、中国に本社をおく調査会社です。   QYResearchでは年間数百タイトルの調査レポートを出版しています。... もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

2024/11/22 10:26

155.52 円

163.34 円

198.56 円

ページTOPに戻る